For those suffering from primary bone cancer — which is cancer that originates in the bones — a promising new medication may be on the horizon. The drug, called CADD522, works by blocking a gene ...

Tumor cells are known to be fickle sleeper agents, often lying dormant in distant tissues for years before reactivating and forming metastasis. Numerous factors have been studied to understand why the ...

A recent review is transforming the landscape of craniomaxillofacial bone regeneration with the introduction of personalized bioceramic grafts. This pioneering research explores the fabrication and ...

Researchers have developed a magnetic nanomaterial that can kill bone cancer cells and support bone regeneration at the same ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. A Regeneron Pharmaceuticals drug succeeded in a pivotal study in an ultra ...

Researchers at BRIC-National Institute of Animal Biotechnology have developed multifunctional strontium-doped nanoparticles ...

The interplay between bone and cardiovascular systems represents a dynamic and rapidly expanding field of biomedical research. Scientific advances have ...

In my time as a sports dietitian, I have consistently argued that understanding bone health—and the factors that contribute ...